drugset / Trial / NCT00660660

Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US

NCT00660660

Phase 4 Completed 276 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this research study is to compare the safety and effectiveness (how well the medicine works) of esomeprazole (study drug) to placebo (a capsule that does not contain any medication) taken daily in relieving nighttime heartburn and problems sleeping in patients with gastroesophageal reflux disease (GERD).

Timeline

Start
2008-04
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 20 mg